LANSING - Just 1,329 Michiganders have completed enrollment in a health insurance plan through the deeply troubled federal exchange in the first month of operations, a pace that would put enrollment numbers a whopping 95 percent below the forecast for enrollment in the first year. The U.S. Department of Health and Human Services released the
LANSING - Sen. Bruce Caswell said Wednesday that the health care industry is complicated, but he's hoping his bill allowing pharmacists to receive up to three national drug codes from pharmaceutical benefits managers could bring some clarity to the industry's drug pricing. "The core issue here was to create, for pharmacies across the state, the
LANSING - Michigan will receive nearly $42 million from the pharmaceutical manufacturer Johnson & Johnson as part of a national settlement over the use of drug marketing schemes for anti-psychotic drugs to both the elderly and children. Most of the money to be paid to the state will go back into the Medicaid program, which
DETROIT - The Grand Valley State University board, meeting Friday at its new Detroit Center near Comerica Park, approved the purchase of 11 acres of land near downtown Grand Rapids to expand the university's health campus at the east end of Grand Rapids' multi-billion-dollar Medical Mile. The university already owns four acres of property adjacent
GRAND RAPIDS - More Michigan physicians and other healthcare providers than ever before will be able to share medical records electronically under an agreement between the Great Lakes Health Information Exchange and Michigan Health Connect. The collaboration between the state?s two largest providers of health information exchange means that medical professionals treating about half the
ANN ARBOR - Enzo Life Sciences has expanded its portfolio of drug discovery screening platforms with the introduction of the new Leading Ligh Sclerostin-LRP Screening System. The Leading Light Sclerostin-LRP Screening System was developed to meet the market need for a simple, sensitive biochemical screening assay for detection of sclerostin inhibitors (antagonists of the Wnt
KALAMAZOO - 2013 has been one of the strongest years in many for biotech and medical device companies to go public, a California venture capitalist said Tuesday at the MichBio Expo. Mike Carusi, General Partner of Advanced Technology Partners based in Palo Alto, California. Carusi is a General Partner and Team Leader for Lightstone Ventures,
KALAMAZOO ? The 2013 MichBio Expo & Conference is set for Oct. 15-16 at the Radisson Plaza Hotel in downtown Kalamazoo. The 2013 MichBio Expo will present the annual Emerging Biosciences Showcase and will feature pitches from 9 early stage, innovative bioscience start-ups across multiple industry sectors. MichBio is now accepting applications for the Emerging
ANN ARBOR ? Rubicon Genomics reported that its ThruPLEXTM-FD Prep Kits contributed to the success of a breakthrough study recently published in Nature1 that showed that genomic data extracted from the plasma of cancer patients can be used to track drug resistance and potentially guide treatment. The proof-of-principle study showed that by sequencing tumor exomes
KALAMAZOO ? Medical device giant Stryker has agreed to buy Mako Surgical Corp. for $1.65 billion to add technology for robot-assisted surgery. Investors in Mako will receive $30 a share from Stryker, the companies said Wednesday in a statement. The offer carries an 86 percent premium over Fort Lauderdale-based Mako's closing price Tuesday. Mako, founded